Recent advances in transfusions in neonates/infants
Open Access
- 18 May 2018
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 7, 609
Abstract
Transfusions of red blood cells (RBCs), platelets, and plasma are critical therapies for infants and neonates (particularly preterm neonates) in the neonatal intensive care unit, who are the most frequently transfused subpopulation across all ages. Although traditionally a significant gap has existed between the blood utilization and the evidence base essential to adequately guide transfusion practices in infants and neonates, pediatric transfusion medicine is evolving from infancy and gradually coming of age. It is entering an exciting era with recognition as an independent discipline, a new and evolving high-quality evidence base for transfusion practices, novel technologies and therapeutics, and national/international collaborative research, educational, and clinical efforts. Triggers and thresholds for red cell transfusion are accumulating evidence with current phase III clinical trials. Ongoing trials and studies of platelet and plasma transfusions in neonates are anticipated to provide high-quality evidence in years to come. This article aims to summarize the most current evidence-based practices regarding blood component therapy in neonates. Data on the use of specific components (RBCs, plasma, and platelets) are provided. We attempt to define thresholds for anemia, thrombocytopenia, and abnormal coagulation profile in neonates to highlight the difficulties in having a specific cutoff value in neonates and preterm infants. Indications for transfusion of specific products, transfusion thresholds, and current practices and guidelines are provided, and possible adverse outcomes and complications are discussed. Finally, the critical research knowledge gaps in these practices as well as ongoing and future research areas are discussed. In an era of personalized medicine, neonatal transfusion decisions guided by a strong evidence base must be the overarching goal, and this underlies all of the strategic initiatives in pediatric and neonatal transfusion research highlighted in this article.Keywords
This publication has 55 references indexed in Scilit:
- A Cluster of Cases of Babesia microti Among Neonates Traced to a Single Unit of Donor BloodThe Pediatric Infectious Disease Journal, 2018
- Pediatric and Neonatal Transfusion Medicine: A Roadmap for ResearchTransfusion Medicine Reviews, 2016
- Neonatal Transfusion MedicineClinics in Perinatology, 2015
- Temporal changes in blood product usage in preterm neonates born at less than 30 weeks' gestation in CanadaTransfusion, 2015
- One size will never fit all: the future of research in pediatric transfusion medicinePediatric Research, 2014
- Transfusion‐related lung injury in children: a case series and review of the literatureTransfusion, 2013
- A cluster of transfusion-associated babesiosis in extremely low birthweight premature infantsJournal of Perinatology, 2012
- Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996–2005British Journal of Haematology, 2008
- Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm InfantsPediatrics, 2005
- Changing practices of red blood cell transfusions in infants with birth weights less than 1000 gThe Journal of Pediatrics, 2000